Tralokinumab (Genetical Recombination)



Tralokinumab is a recombinant human IgG4 monoclonal antibody against human interleukin-13. Tralokinumab is produced in mouse myeloma (NS0) cells. Tralokinumab is a glycoprotein (molecular weight: ca. 147,000) composed of 2 H-chains (γ4-chains) consisting of 449 amino acid residues each and 2 L-chains (λ-chains) consisting of 214 amino acid residues each.

[1044515-88-9]